 Diabetic patients will include with critical ischemia chronicle of at least a low member limb CLI and without possibilities of revascularization. 48 evaluable patients will be included, of which 36 patients will be included in the experimental group 12 for every cellular group and 12 in the group control by conventional treatment. The population to studying will be constituted by 48 evaluable patients. 